Different inflammatory phenotypes drive varying immunosuppressive responses during COPD exacerbations, indicating a need for personalized strategies.
Key cytokines and immune pathways are involved in the modulation of the immune response associated with COPD exacerbations and inflammatory phenotypes.
This observational analysis used detailed clinical data to assess the role of immune responses in exacerbated COPD cases over a defined period.
Findings highlight potential new approaches for treatment aimed at specific inflammatory profiles in COPD, yet further validation in larger trials is necessary.